24 Results

EASL Recommendations on Treatment of Hepatitis C 2018

These European Association for the Study of the Liver Recommendations on Treatment of Hepatitis C describe the optimal management of patients with acute and chronic HCV infections in 2018 and onwards.

EASL Clinical Practice Guidelines on hepatitis E virus infection

Infection with hepatitis E virus (HEV) is a significant cause of morbidity and mortality, representing an important global health problem. Our understanding of HEV has changed completely over the past decade.

EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

The following Clinical Practice Guidelines (CPGs) represent the first CPGs on the management of decompensated cirrhosis.

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

This Clinical Practice Guideline presents updated recommendations for the optimal management of HBV infection.

EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure

The term acute liver failure (ALF) is frequently applied as a generic expression to describe patients presenting with or developing an acute episode of liver dysfunction.

Guidelines on the management of abnormal liver blood tests

These guidelines are intended to be of use for all healthcare professionals, although with a major focus on the asymptomatic patient with abnormal liver blood tests.

AISF-SIMTI position paper: the appropriate use of albumin in patients with liver cirrhosis

The use of human albumin is common in hepatology since international scientific societies support its administration to treat or prevent severe complications of cirrhosis, such as the prevention of post-paracentesis circulatory dysfunction...

Management of Adult Patients with Ascites Due to Cirrhosis: Update 2012

Cirrhosis is the eighth leading cause of death in the United States, if expanded liver diagnosis codes are used.

EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.

Ascites is the most common complication of cirrhosis, and ∼60% of patients with compensated cirrhosis develop ascites within 10 years during the course of their disease. 

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

The Clinical Practice Guidelines propose recommendations for the diagnosis, treatment and follow-up of non-alcoholic fatty liver disease (NAFLD) patients and...

Load more